Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Сахарный диабет 2 типа у детей

Список литературы

  1. Дедов И.И. Сахарный диабет у детей и подростков / Дедов И.И., Кураева Т.Л., Петеркова В.А. – Москва: ГЭОТАР-Медиа, 2013. – 271 с.
  2. Петеркова В.А. Особенности диабета типа 2 у детей и подростков / Петеркова В.А., Кураева Т.Л., Еремина И.А. // Сахарный диабет типа 2: от теории к практике. Под редакцией академика РАН И.И. Дедова, члена-корреспондента РАН М.В. Шестаковой. – Москва: ООО
  3. Studying progression from glucose intolerance to type 2 diabetes in obese children / I.A. Dubinina [et al.] // Diabetes & Metabolic Syndrome: Clinical Research & Reviews. – 2014. – Vol. 8.
  4. Проблемы диагностики и терапии сахарного диабета 2 типа у детей и подростков / Кураева Т.Л. [и др.] // Материалы V Городской научно-практическая конференции
  5. Дедов, И.И. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета / И.И. Дедов, М.В. Шестакова, О.К. Викулова. – 2017. – Т. 1. – № 20. – С. 13-41.
  6. Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009 / D. Dabelea [et al.] // JAMA. – 2014. – Vol. 311. – № 17. – P. 1778.
  7. Clinical polymorphism of type 2 diabetes in children – the first study in Russia / I.A. Eremina [и др.] // Problems of Endocrinology. – 2015. – Т. 61. – № 6. – С. 10-16.
  8. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents / E.J. Mayer-Davis [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 7-19.
  9. Sabin, M.A. Type 2 diabetes in children: Type 2 diabetes in children / M.A. Sabin // Clinical Obesity. – 2013. – Vol. 3. – № 3-4. – P. 112-116.
  10. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation / World Health Organization, International Diabetes Federation. – 2006.
  11. The Presence of GAD and IA-2 Antibodies in Youth With a Type 2 Diabetes Phenotype: Results from the TODAY study / G.J. Klingensmith [et al.] // Diabetes Care. – 2010. – Vol. 33. – № 9.
  12. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth / P. Zeitler [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 28-46.
  13. HbA 1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes / P. Zeitler [et al.] // Diabetes Care. – 2015. – Vol. 38. – № 12. – P. 2285-2292.
  14. American Diabetes Association. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes–2018 / American Diabetes Association // Diabetes Care. – 2018. – Vol. 41. – № Supplement 1. – P. S73-S85.
  15. Glycemic Control in Youth with Diabetes: The SEARCH for Diabetes in Youth Study / D.B. Petitti [et al.] // The Journal of Pediatrics. – 2009. – Vol. 155. – № 5. – P. 668-672.e3.
  16. Еремина И.А. Метформин в лечении сахарного диабета 2-го типа у детей и подростков
  17. Effect of Metformin in Pediatric Patients With Type 2 Diabetes: A randomized controlled trial / K.L. Jones [et al.] // Diabetes Care. – 2002. – Vol. 25. – № 1. – P. 89-94.
  18. A clinical trial to maintain glycemic control in youth with type 2 diabetes / TODAY Study Group [et al.] // The New England Journal of Medicine. – 2012. – Т. 366. – № 24. – P. 2247-2256.
  19. American Diabetes Association. 13. Children and Adolescents: Standards of Medical Care in Diabetes–2019 / American Diabetes Association // Diabetes Care. – 2019. – Vol. 42. –
  20. Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association / S. Arslanian [et al.] // Diabetes Care. – 2018. – Vol. 41. – № 12. – P. 2648-2668.
  21. Liraglutide in Children and Adolescents with Type 2 Diabetes / W.V. Tamborlane [et al.] // New England Journal of Medicine. – 2019. – Vol. 381. – № 7. – P. 637-646.
  22. New Insulin Delivery Recommendations / A.H. Frid [et al.] // Mayo Clinic Proceedings. – 2016. – Т. 91. – № 9. – P. 1231-1255.
  23. Техника инъекций и инфузии при лечении сахарного диабета. Методическое руководство. / Майоров А.Ю. [и др.]. – Москва: ООО «АРТИНФО», 2018. – 64 с.
  24. ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes / C.E. Smart [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 136-154.
  25. American Diabetes Association. 4. Lifestyle Management: Standards of Medical Care in Diabetes–2018 / American Diabetes Association // Diabetes Care. – 2018. – Vol. 41. –
  26. Barlow, S.E. Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report / S.E. Barlow // Pediatrics. – 2007. – Vol. 120. – № Supplement 4. – P. S164-S192.
  27. A Systematic Review and Meta-Analysis of the Effect of Lifestyle Modification on Metabolic Control in Overweight Children / A.S.-Y. Lien [et al.] // Evidence-Based Complementary and Alternative Medicine. – 2017. – Vol. 2017. – P. 1-12.
  28. Dhuper, S. Managing Cardiovascular Risk in Overweight Children and Adolescents / S. Dhuper, S. Buddhe, S. Patel // Pediatric Drugs. – 2013. – Vol. 15. – № 3. – P. 181-190.
  29. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society / M.D. Jensen [et al.] // Circulation. – 2014. – Vol. 129. – № 25 suppl 2. – P. S102-S138.
  30. Availability and night-time use of electronic entertainment and communication devices are associated with short sleep duration and obesity among Canadian children: EECD use and obesity among children / H. Chahal [et al.] // Pediatric Obesity. – 2013. – Vol. 8. – № 1. – P. 42-51.
  31. Lane, A. Screen Time Increases Risk of Overweight and Obesity in Active and Inactive 9-Year-Old Irish Children: A Cross Sectional Analysis / A. Lane, M. Harrison, N. Murphy // Journal of Physical Activity and Health. – 2014. – Т. 11. – № 5. – С. 985-991.
  32. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes / P. Adolfsson [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 205-226.
  33. A Systematic Review of Interventions to Improve Diabetes Care in Socially Disadvantaged Populations / R.H. Glazier [et al.] // Diabetes Care. – 2006. – Vol. 29. – № 7. – P. 1675-1688.
  34. Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities / K.J. Nadeau [et al.] // Diabetes Care. – 2016. – Vol. 39. – № 9. – P. 1635-1642.
  35. Exaggerated Adrenarche and Hyperinsulinism in Adolescent Girls Born Small for Gestational Age / L. Ibáñez [et al.] // The Journal of Clinical Endocrinology & Metabolism. – 1999. – Vol. 84. – № 12. – P. 4739-4741.
  36. Dabelea, D. Maternal Environment and the Transgenerational Cycle of Obesity and Diabetes
  37. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan / H. Yokoyama [et al.] // Kidney International. – 2000. – Vol. 58. – № 1. – P. 302-311.
  38. Stevens, P.E. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline / P.E. Stevens, A. Levin, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members // Annals of Internal Medicine. – 2013. – Т. 158. – № 11. – P. 825-830.
  39. New equations to estimate GFR in children with CKD / G.J. Schwartz [et al.] // Journal of the American Society of Nephrology: JASN. – 2009. – Т. 20. – № 3. – P. 629-637.
  40. Schwartz, G.J. Measurement and estimation of GFR in children and adolescents / G.J. Schwartz, D.F. Work // Clinical journal of the American Society of Nephrology: CJASN. – 2009. – Т. 4. – № 11. – P. 1832-1843.
  41. Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline / K.C. Copeland [et al.] // The Journal of Clinical Endocrinology & Metabolism. – 2011. – Vol. 96. – № 1. – P. 159-167.
  42. TODAY Study Group. Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes: The TODAY clinical trial / TODAY Study Group // Diabetes Care. – 2013. – Vol. 36. – № 6.
  43. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy / E.J. Lewis [et al.] // New England Journal of Medicine. – 1993. – Vol. 329. – № 20. – P. 1456-1462.
  44. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review / G.F.M. Strippoli [et al.] // BMJ (Clinical research ed.). – 2004. – Т. 329. – № 7470. – P. 828.
  45. Antihypertensive agents for preventing diabetic kidney disease / J. Lv [et al.] // Cochrane Database of Systematic Reviews. – 2012.
  46. Antihypertensive agents for preventing diabetic kidney disease / G.F. Strippoli [et al.] // Cochrane Database of Systematic Reviews / ed. The Cochrane Collaboration. – Chichester, UK: John Wiley & Sons, Ltd, 2005. – P. CD004136.pub2.
  47. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis / H.-Y. Wu [et al.] // BMJ. – 2013. – Vol. 347. – № oct24 2. – P. f6008-f6008.
  48. The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropath / L Barkai 1, A Soós, I Vámosi – Orv Hetil.-1996 Nov 17;137(46):2565-8.
  49. Dinneen, S.F. The Association of Microalbuminuria and Mortality in Non–Insulin-Dependent Diabetes Mellitus: A Systematic Overview of the Literature / S.F. Dinneen // Archives of Internal Medicine. – 1997. – Vol. 157. – № 13. – P. 1413.
  50. American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes–2018 / American Diabetes Association // Diabetes Care. – 2018. – Vol. 41.
  51. Timing Is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors / J. Wong [et al.] // Diabetes Care. – 2008. – Vol. 31. – № 10. – P. 1985-1990.
  52. Long-Term Complications and Mortality in Young-Onset Diabetes: Type 2 diabetes is more hazardous and lethal than type 1 diabetes / M.I. Constantino [et al.] // Diabetes Care. – 2013. – Vol. 36. – № 12. – P. 3863-3869.
  53. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents / K.C. Donaghue [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 262-274.
  54. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy / M.J. Martinez-Zapata [et al.] // Cochrane Database of Systematic Reviews. – 2014.
  55. Simunovic, M.P. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis / M.P. Simunovic, D.A.L. Maberley // Retina. – 2015. – Vol. 35. – № 10. – P. 1931-1942.
  56. TODAY Study Group. Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial / TODAY Study Group // Diabetes Care. – 2013. – Vol. 36. – № 6. – P. 1772-1774.
  57. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study / B.L. Rodriguez [et al.] // Diabetes Care. – 2006.
  58. Кардиоваскулярная форма автономной нейропатии у подростков с сахарным диабетом 2 типа / И.А. Еремина [и др.] // Проблемы эндокринологии. – 2014. – Т. 60. – № 5. – С. 15-21.
  59. Maffi, P. The Burden of Diabetes: Emerging Data / P. Maffi, A. Secchi // Developments in Ophthalmology / eds. F. Bandello [et al.]. – S. Karger AG, 2017. – Vol. 60. – P. 1-5.
  60. Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study / M. Jaiswal [et al.] // Pediatric Diabetes. – 2018.
  61. Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents / K.C. Copeland [et al.] // PEDIATRICS. – 2013. – Vol. 131. – № 2. – P. 364-382.
  62. EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report / EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS // PEDIATRICS. – 2011. – Vol. 128. –
  63. TODAY Study Group. Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes: The TODAY clinical trial / TODAY Study Group // Diabetes Care. – 2013. – Vol. 36. – № 6. – P. 1758-1764.
  64. Batisky, D.L. What Is the Optimal First-Line Agent in Children Requiring Antihypertensive Medication? / D.L. Batisky // Current Hypertension Reports. – 2012. – Vol. 14. – № 6. – P. 603-607.
  65. Blowey, D.L. Update on the Pharmacologic Treatment of Hypertension in Pediatrics: Update on Pharmacologic Treatment in Pediatrics / D.L. Blowey // The Journal of Clinical Hypertension. – 2012. – Vol. 14. – № 6. – P. 383-387.
  66. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline / R.S. Legro [et al.] // The Journal of Clinical Endocrinology & Metabolism. – 2013. – Vol. 98. – № 12. – P. 4565-4592.
  67. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease / K.P. Newton [et al.] // JAMA Pediatrics. – 2016. – Vol. 170. – № 10. – P. e161971.
  68. Nadeau, K.J. Type 2 Diabetes in Children is Frequently Associated with Elevated Alanine Aminotransferase: / K.J. Nadeau, G. Klingensmith, P. Zeitler // Journal of Pediatric Gastroenterology and Nutrition. – 2005. – Vol. 41. – № 1. – P. 94-98.
  69. Sundaram, S.S. The metabolic syndrome and nonalcoholic fatty liver disease in children: /
  70. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study / T. Reinehr [et al.] // Archives of Disease in Childhood. – 2009. – Vol. 94. – № 6. – P. 437-442.
  71. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis / P. Angulo [et al.] // Hepatology. – 1999. – Vol. 30. – № 6. – P. 1356-1362.
  72. Sleep-disordered breathing and type 2 diabetes / J.E. Shaw [et al.] // Diabetes Research and Clinical Practice. – 2008. – Vol. 81. – № 1. – P. 2-12.
  73. Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes / G.D. Foster [et al.] // Diabetes Care. – 2009. – Vol. 32. – № 6. – P. 1017-1019.
  74. ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes / M.B. Abraham [et al.] // Pediatric Diabetes. – 2018. – Vol. 19. – P. 178-192.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу